Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment of dyspnea. Low-dose oral or sublingual opioids are effective in treating dyspnea.

Purpose. The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF) lung disease is described. Dyspnea, the sensation of breathlessness or labored ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

Ideas, insights and resources to inspire opioid stewardship. The use and misuse of opiate-based prescription, synthetic and illicit drugs, are a major public health concern. In 2021, 107,622 lives ...

CLEVELAND, Ohio — Do music therapy and acupuncture help patients manage pain without opioids? University Hospitals will use a nearly $1.5 million federal grant to find out. The grant allows UH ...

Dyspnea, or shortness of breath, is a common COPD symptom. You may experience different levels of dyspnea, but you can take steps to make breathing easier and help preserve your lung health. If ...

Dyspnea in conjunction with abnormal lung sounds by auscultation, hypoxemia, tachypnea, cough and/or fever, sputum, or chest pain is the most effective differentiation identification tool for severe ...

The Sacklers will no longer have liability protection from future lawsuits. The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial ...

The settlement is the largest to date with respect to individuals’ contributions to the opioid crisis. A Thursday announcement from the Tennessee Attorney General Jonathan Skrmetti’s office ...

Various treatment options are available, including anticonvulsants, certain antidepressants, mild opioids, and some topical treatments. Scientists define nerve pain, also known as neuropathic pain ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug Administration approved the opioid OxyContin for the treatment of chronic pain.